Ventricular arrhythmias after left ventricular assist device

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 3, 2013, Pages 648-654

  Nakahara, Shashima ^a   Chien, Christopher ^a   Gelow, Jill ^a   Dalouk, Khidir ^a   Henrikson, Charles A ^a   Mudd, James ^a   Stecker, Eric C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Arrhythmia (heart rhythm disorders); Heart failure; Ischemic heart failure; Ventricular assist device; Ventricular assist device remodeling

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; LIDOCAINE; MAGNESIUM; MEXILETINE; POTASSIUM; SOTALOL;

ADRENERGIC STIMULATION; ANTICOAGULANT THERAPY; ARTICLE; ASSISTED CIRCULATION; BIVENTRICULAR ASSIST DEVICE; BLOOD CLOTTING; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CARDIOVERSION; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; DEFIBRILLATION; DISEASE PREDISPOSITION; ELECTROCARDIOGRAM; GRAFT RECIPIENT; HEART AFTERLOAD; HEART ARREST; HEART CATHETERIZATION; HEART ELECTROPHYSIOLOGY; HEART PRELOAD; HEART REPOLARIZATION; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MAGNESIUM BLOOD LEVEL; MAXIMUM TOLERATED DOSE; ORGAN PERFUSION; PERICARDIOCENTESIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; QT PROLONGATION; RADIOFREQUENCY ABLATION; SUDDEN CARDIAC DEATH; TELEMETRY; TOTAL ARTIFICIAL HEART; AGED; ARRHYTHMIA (HEART RHYTHM DISORDERS); CATHETER ABLATION; COMPARATIVE STUDY; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; ISCHEMIC HEART FAILURE; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR ASSIST DEVICE; VENTRICULAR ASSIST DEVICE REMODELING;

ARRHYTHMIA (HEART RHYTHM DISORDERS); HEART FAILURE; ISCHEMIC HEART FAILURE; VENTRICULAR ASSIST DEVICE; VENTRICULAR ASSIST DEVICE REMODELING;

AGED; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84883019483     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000113     Document Type: Article

References (41)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220.
2. Hertz MI, Aurora P, Benden C, Christie JD, Dobbels F, Edwards LB, Kirk R, Kucheryavaya AY, Rahmel AO, Rowe AW, Stehlik J. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2011 annual reports. J Heart Lung Transplant. 2011;30:1071-1077.
3. Kirklin JK, Naftel DC, Myers SL, Clark ML, Collum SC, Zhang S. Interagency registry for mechanically assisted circulatory support. Quarterly statistical report. Implant dates: June 23, 2006-March 31, 2012. June 20; 2012.
4. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.
5. Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol. 1969;24:723-730.
6. Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH; HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-896.
7. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH; HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-321.
8. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251.
9. Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN 3rd; INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50:741-747.
10. Cao X, Haft J, Dyke DB, Wright S, Pagani FD, Aaronson KD. Increased incidence of ventricular tachycardia following left ventricular assist device implantation with continuous flow rotary pumps. J Card Fail. 2006;12:S45.
11. Ambardekar AV, Allen LA, Lindenfeld J, Lowery CM, Cannon AP, Cleveland JC Jr, Brieke A, Sauer WH. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. J Heart Lung Transplant. 2010;29:771-776.
12. Kühne M, Sakumura M, Reich SS, Sarrazin JF, Wells D, Chalfoun N, Crawford T, Boonyapisit W, Horwood L, Chugh A, Good E, Jongnarangsin K, Bogun F, Oral H, Morady F, Pagani F, Pelosi F Jr. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure. Am J Cardiol. 2010;105:378-382.
13. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol. 2007;99:1151-1153.
14. Ziv O, Dizon J, Thosani A, Naka Y, Magnano AR, Garan H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol. 2005;45:1428-1434.
15. Refaat M, Chemaly E, Lebeche D, Gwathmey JK, Hajjar RJ. Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol. 2008;31:1246-1252.
16. Harding JD, Piacentino V 3rd, Rothman S, Chambers S, Jessup M, Margulies KB. Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail. 2005;11:227-232.
17. Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009;28:733-735.
18. Cantillon DJ, Tarakji KG, Kumbhani DJ, Smedira NG, Starling RC, Wilkoff BL. Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. Heart Rhythm. 2010;7:466-471.
19. Genovese EA, Dew MA, Teuteberg JJ, Simon MA, Kay J, Siegenthaler MP, Bhama JK, Bermudez CA, Lockard KL, Winowich S, Kormos RL. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg. 2009;88:1162-1170.
20. Oswald H, Schultz-Wildelau C, Gardiwal A, Lüsebrink U, König T, Meyer A, Duncker D, Pichlmaier MA, Klein G, Strüber M. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients. Eur J Heart Fail. 2010;12:593-599.
21. Arai H, Swartz MT, Pennington DG, Moriyama Y, Miller L, Peigh P, McBride L. Importance of ventricular arrhythmias in bridge patients with ventricular assist devices. ASAIO Trans. 1991;37:M427-M428.
22. Vollkron M, Voitl P, Ta J, Wieselthaler G, Schima H. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant. 2007;26:819-825.
23. Oz MC, Rose EA, Slater J, Kuiper JJ, Catanese KA, Levin HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol. 1994;24:1688-1691.
24. Busch MC, Haap M, Kristen A, Haas CS. Asymptomatic sustained ventricular fibrillation in a patient with left ventricular assist device. Ann Emerg Med. 2011;57:25-28.
25. Fasseas P, Kutalek SP, Kantharia BK. Prolonged sustained ventricular fibrillation without loss of consciousness in patients supported by a left ventricular assist device. Cardiology. 2002;97:210-213.
26. Fasseas P, Kutalek SP, Samuels FL, Holmes EC, Samuels LE. Ventricular assist device support for management of sustained ventricular arrhythmias. Tex Heart Inst J. 2002;29:33-36.
27. Salzberg SP, Lachat ML, Zünd G, Turina MI. Left ventricular assist device (LVAD) enables survival during 7 h of sustained ventricular fibrillation. Eur J Cardiothorac Surg. 2004;26:444-446.
28. Moroney DA, Swartz MT, Reedy JE, Lohmann DP, McBride LR, Pennington DG. Importance of ventricular arrhythmias in recovery patients with ventricular assist devices. ASAIO Trans. 1991;37:M516-M517.
29. Brenyo A, Rao M, Koneru S, Hallinan W, Shah S, Massey HT, Chen L, Polonsky B, McNitt S, Huang DT, Goldenberg I, Aktas M. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol. 2012;23:515-520.
30. Cantillon DJ, Bianco C, Wazni OM, Kanj M, Smedira NG, Wilkoff BL, Starling RC, Saliba WI. Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support. Heart Rhythm. 2012;9:859-864.
31. Harding JD, Piacentino V 3rd, Gaughan JP, Houser SR, Margulies KB. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation. 2001;104:1241-1247.
32. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik J. Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. Curr Opin Cardiol. 2011;26:245-255.
33. Margulies KB. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J Card Fail. 2002;8(suppl 6):S500-S505.
34. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W; MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275-2283.
35. Oswald H, Klein G, Strüber M, Gardiwal A. Implantable defibrillator with left ventricular assist device compatibility. Interact Cardiovasc Thorac Surg. 2009;8:579-580.
36. Rohit M, Charles JL, Sai-Sudhakar C, Hasan AK, Chan D. A device-device interaction between a Thoratec Heartmate II left ventricular assist device and a St. Jude Atlas (V-193) implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2007;18:E27; author reply E28.
37. Matthews JC, Betley D, Morady F, Pelosi F Jr. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 2007;18:1107-1108.
38. Foo D, Walker BD, Kuchar DL, Thorburn CW, Tay A, Hayward CS, Macdonald P, Keogh A, Kotlyar E, Spratt P, Jansz P. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series. Pacing Clin Electrophysiol. 2009;32:879-887.
39. Ambardekar AV, Lowery CM, Allen LA, Cannon AP, Cleveland JC Jr, Lindenfeld J, Brieke A, Sauer WH. Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads. J Card Fail. 2010;16:327-331.
40. Dandamudi G, Ghumman WS, Das MK, Miller JM. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices. Heart Rhythm. 2007;4:1165-1169.
41. Ensor CR, Paciullo CA, Cahoon WD Jr, Nolan PE Jr. Pharmacotherapy for mechanical circulatory support: a comprehensive review. Ann Pharmacother. 2011;45:60-77.